Cancer Research Donn Young  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 1569-1572, April 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gooderham, N. J.
Right arrow Articles by Mannering, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gooderham, N. J.
Right arrow Articles by Mannering, G. J.

Depression of the Hepatic Cytochrome P-450 Monooxygenase System by Treatment of Mice with the Antineoplastic Agent 5-Azacytidine1

N. J. Gooderham and G. J. Mannering2

Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455

The effects of 5-azacytidine (5-AC) administration on the hepatic cytochrome P-450 systems of mice were studied. A single i.p. dose of 5-AC (25 mg/kg) to male Swiss-Webster mice caused about a 50% depression of microsomal cytochromes P-450 and b5 and of ethylmorphine N-demethylase and ethoxycoumarin O-deethylase activities. Depression was greatest 24 h after treatment; by 48 to 72 h, cytochromes and drug metabolism had returned to near control values. Reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase activity was also depressed by 5-AC, whereas reduced nicotinamide adenine dinucleotide-cytochrome c reductase was not. Incubation of 5-AC with microsomes produced no effect on drug metabolism. The prolongation of hexobarbital sleeping time by 5-AC showed that drug metabolism is also impaired by 5-AC in vivo. These studies may have important clinical implications when certain drugs are coadministered with 5-AC.

1 This investigation was supported by USPHS Grant GM27780. A preliminary report of this work was presented at the 1983 Annual Meeting of the American Society of Pharmacology and Experimental Therapeutics, Philadelphia, PA (45).

2 To whom requests for reprints should be addressed.

Received 9/18/84. Revised 12/14/84. Accepted 12/28/84.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
W.-H. Chan, T.-L. Chen, R.-M. Chen, W.-Z. Sun, and T.-H. Ueng
Propofol metabolism is enhanced after repetitive ketamine administration in rats: the role of cytochrome P-450 2B induction
Br. J. Anaesth., September 1, 2006; 97(3): 351 - 358.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. H. Mostafa, S. A. Sheweita, and P. J. O'Connor
Relationship between Schistosomiasis and Bladder Cancer
Clin. Microbiol. Rev., January 1, 1999; 12(1): 97 - 111.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.